From London School of Hygiene and Tropical Medicine.
It is a strange time to be writing about the work of the UK ME/CFS Biobank (UKMEB); as I write, our office has been closed for over two months and clinical visits have been paused indefinitely; samples cannot currently be distributed. COVID-19 has created many challenges to our work and the research of many others, but it may also make the work of the Biobank more important than ever and provide various opportunities for future studies and discoveries. At this time, we would like to draw your attention to the rich dataset we have available to researchers worldwide, that may inspire new research applications during this period when existing lab work may be paused.
The UKMEB is Europe’s first biobank devoted to ME/CFS. We have been collecting since 2013, and now have a repository of over 30,000 aliquots of blood, collected from people with ME, multiple sclerosis, as well as healthy controls. We have recruited people via the NHS, from partner organisations, and from the public.
To read the rest of this story, click on the link below: